Construction and Characterization of Retroviral Vectors Expressing Biologically Active Human Interleukin-12

Human Gene Therapy

Volumn 5, Issue 12, 1994, Pages 1493-1506

  Zitvogel, Laurence ^a   Tahara, Hideaki ^a   Cai, Quan ^a   Storkus, Walter J ^a   Muller, Gunhild ^a   Maurice, Gately ^c   Wolf, Stanley F ^b   Robbins, Paul D ^a   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

ADENOCARCINOMA; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CELL STRAIN 3T3; CLINICAL TRIAL; CLONING VECTOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE TRANSFER; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LUNG CARCINOMA; MARKER GENE; MELANOMA CELL; NATURAL KILLER CELL; NONHUMAN; RAT; RETROVIRUS; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; TUMOR REGRESSION;

ANIMALS; BIOPOLYMERS; DNA, COMPLEMENTARY; ENCEPHALOMYOCARDITIS VIRUS; GENE THERAPY; GENES, VIRAL; GENETIC CODE; GENETIC MARKERS; GENETIC VECTORS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MICE; RECOMBINANT PROTEINS; RETROVIRIDAE; RIBOSOMES; RNA, MESSENGER; TRANSFECTION; VIRAL STRUCTURAL PROTEINS;

ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0028625325     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.1994.5.12-1493     Document Type: Article

References (63)

1. AFONSO, L.C., SCHARTON, T.M., VIEIRA, L.Q., WYSOCKA, M., TRINCHIERI, G., and SCOTT, P. (1994). The adjuvant effect of IL-12 in a vaccine against Leishmania major. Science 263, 235-236.
2. AOKI, T., TASHIRO, K., MIATAKE, S.I., KINASHI, T., NA-KANO, T., ODA, Y., KIKUCHI, H., and HONGI, T. (1992). Expression of murine IL-7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc. Natl. Acad. Sci. USA 89, 3850-3854.
3. ASHER, A.L., MULE, J.J., KASID, A., RESTIFO, N.P., SALO, J.C., REICHERT, C.M., JAFFE, G., FENDLY, B., KRIEGLER, M., and ROSENBERG, S.A. (1991). Murine tumor models transduced with the gene for TNF-a. J. Immunol. 146, 3227-3234.
4. BANDARA, G., MUELLER, G.M., GALEA-LAURI, J., TINDAL, M.H., SUCHANEK, M.K., GEORGESCU, H.I., HUNG, G.L., GLORIOSO, J.C., ROBBINS, P.D., and EVANS, C.H. (1993). Intraarticular expression of the Interleukin-1 Receptor antagonist protein by ex-vivo gene transfer. Proc. Natl. Acad. Sci. USA 90, 10764-10768.
5. BASKAR, S., OSTRAND-ROSENBERG, S., NABAVI, N., NA-DLER, L., FREEMAN, G., and GLIMCHER, L. (1993). Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 90, 5687-5690.
6. BERTAGNOLLI, M.M., LIN, B.Y., YOUNG, D., and HERRMANN, S.H. (1992). IL12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149, 3778.
7. BLANKENSTEIN, T., QIN, Z., UBERLA, K., MULLER, W., ROSEN, H., VOLK, H.D., and DIAMENSTEIN, T. (1991). Tumor suppression after tumor cell targeted TNFa gene transfer. J. Exp. Med. 173, 1047-1052.
8. BRUNDA, M.J., LEOPOLDO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F., and GATELY, M.K. (1993). Antitumor and antimetastatic activity of IL-12 against murine tumors. J. Exp. Med. 178, 1223-1230.
9. CHEN, C., and OKAYAMA, H. (1987). High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
10. CHAN, S.H., KOBAYASHI, D., SANTOLI, D., PERUSSIA, B., and TRINCHIERI, G., (1992), Mechanisms of IFN 7-induction by NKSF. Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148, 92.
11. CHEN, L., ASHE, S., BRADY, W.A., HELLSTROM, I., HELL-STROM, K.E., LEDBETTER, J.A., McGOWAN, P., and LINS-LEY, P.S. (1992). Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102.
12. CHEN, L., LINSLEY, P.S., and HELLSTROM, K.E. (1993). Costimulation of T cells for tumor immunity. Immunol. Today 14, 483-486.
13. CHIZZONITE, R., TRUITT, T., PODLASKI, F.J., WOLITSKY, A.G., QUINN, P., NUNES, P., STERN, A.S., and GATELY, M.K. (1991). IL12; monoclonal antibodies specific for the 40 kDa subunit block receptor binding and biologic activity on activated human lymphocytes. J. Immunol. 147, 1548-1556.
14. COLOMBO, M.P., FERRARI, G., STOPPACCIARO, A., PARENZA, M., RODOLFO, M., MAVILIO, F., and PARMIAMI, G. (1991). G-CSF gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J. Exp. Med. 173, 889-897.
15. D-ANDREA, A., RENGARAJU, M., VALIANTE, N.M., CHE-HIMI, I., KUBIN, M., ASTE, M., CHAN, S.H., KOBAYASHI, M., YOUNG, D., NICKBARG, E., WOLF, S.F., and TRINCHIERI, G. (1992). Production of NKSF/IL12 by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387-1398.
16. DANOS, O. (1991). Construction of retroviral packaging cell lines. In Methods in Molecular Biology, Vol. 5: Practical Molecular Virology: Viral Vectors for Gene Expression. M. Collins, ed. (The Humana Press Inc., Clifton, NJ) pp. 17-27.
17. DANOS, O., and MULLIGAN, R.C. (1988) Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85, 6460-6464.
18. DESAI, B.B., QUINN, P.M., WOLITSKY, A.G., MONGINI, P.K., CHIZZONITE, R., and GATELY, M.K. (1992). IL-12 Receptors II: Distribution and regulation of receptor expression. J. Immunol. 148, 3125-3132.
19. DRANOFF, G, J AFFEE, E.M., LAZENBY, A., GOLUMBECK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D.M., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine GMCSF stimulates potent, specific and long lasting antitumor immunity, Proc. Natl. Acad. Sci. USA 90, 3539-3543.
20. ELDER, E.M., LOTZE, M.T., and WHITESIDE, T.L. (1994) Methods for generation of genetically-modified fibroblasts for immunotherapy of cancer. In Methods in Molecular Biology: Gene Therapy Protocols. P. Robbins, ed. (in press).
21. FEARON, E.R., PARDOLL, D.M., ITAYA, T., GOLUMBECK, P., LEVITSKY, H.I., SIMONS, J.W., KARASUYAMA, H., VO-GELSTEIN, B., and FROST, P. (1990). Interleukin 2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60, 397-403.
22. GAGE, P.J., SAVER, B., LEVINE, M., and GLORIOSO, J.C. (1992). A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into Herpes-Simplex-Virus type 1 genome. J. Virol. 66, 5509-5515.
23. GANSBACHER, B., ZIER, K., DANIELS, B., CRONIN, K., BAN-NERJI, R., and GILBOA, E. (1990a). Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172, 1217-1224.
24. GANSBACHER, B., BANNERJI, R., DANIELS, B., ZIER, K., CRONIN, K., and GILBOA, E. (1990b). Retroviral vector mediated IFNg gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res. 50, 7820-7825.
25. GASTE, G., FINSTAD, C.L., GUARINI, A., BOSL, G., GILBOA, E., BANDER, N.H., and GANSBACHER, B. (1992). Retroviral vector mediated lymphokine gene transfer into human renal cancer cells. Cancer Res. 52, 6229-6236.
26. GATELY, M.K., DESAI, B.B., WOLITSKY, A.G., QUINN, P.M., DWYER, C.M., PODLASKI, F.J., FAMILETTI, PC., SINI-GAGLIA, F., CHIZZONNITE, R., and GUBLER, U. (1991). Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12. J. Immunol. 147, 874.
27. GATELY, M.K., WOLITSKY, A.G., QUINN, P.M., and CHIZZONITE, R. (1992). Regulation of human cytolytic lymphocyte responses by IL-12. Cell Immunol. 143, 127.
28. GATELY, M.K., WARRIER, R.R., HONASOGE, S., CARVAJAL, D.M., FAHERTY, D.A., CONNAUGHTON, S.E., ANDERSON, T.D., SARMIENTO, U., HUBBARD, B.R., and MURPHY, M. (1994). Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN7 in vivo. Int. Immunol. 6, 157-167.
29. GAZZINELLI, R.T., HIENY, S., WYNN, T.A., WOLF, S., and SHER, A. (1993). IL-12 is required for the T lymphocyte independent induction of IFN y by an intracellular parasite and induces resistance in T cell deficient hosts. Proc. Natl. Acad. Sci. USA 90, 6115-6119.
30. GERMANN, T., PARTENHEIMER, A., and RUDE, E. (1990). Requirements for the growth of Th 1 lymphocytes clones. Eur. J. Immunol. 20, 2035.
31. GERMANN, T., MATTNER, F., PARTENHEIMER, A., SCHMITT, E., RESKE KUNZ, A.B., FISCHER, H.G., and RUDE, E. (1992). Different accessory function for Thl cells of bone marrow derived macrophages cultured in GM-CSF or M-CSF. Int. Immunol. 4, 755.
32. GHATTAS, I.R., SANES, J R., and MAJORS, J.E. (1991). The en-cephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11, 5848-5859.
33. GOLUMBECK, P.T., LAZENBY, A.J., LEVITSKY, H.I., JAFFEE, E.M., KARASUYAMA, H., BAKER, M., and PARDOLL, D.M. (1991). Treatment of established renal cancer by tumor cells engineered to secrete IL-4. Science 254, 713-716.
34. GUBLER, U., CHUA, A.O., SCHOENHAUT, D.S., DWYER, C.M., and GATELY, M.K. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88, 4143-4147.
35. HOCK, H., DORSCH, M., DIAMANTSTEIN, T., and BLANKENSTEIN, T. (1991). IL-7 induces CD4-I- T cell dependent tumor rejection. J. Exp. Med. 174, 1291-1298.
36. HOCK, H., DORSCH, M., KUNZENDORF, U., QIN, Z., DIAMANTSTEIN, T., and BLANKENSTEIN, T. (1993). Mechanisms of rejection induced by tumor cell-targeted gene transfer of IL-2, IL-4, IL-7, TNF or IFN7. Proc. Natl. Acad. Sci. USA 90, 2774-2778.
37. HSIEH, C.S., MACATONIA, S.E., TRIPP, C.S., WOLF, S.F., O-GARRA, A., and MURPHY, K.M. (1993). Development of Thl CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
38. JAFFEE, E.M., DRANOFF, G., COHEN, L.K., HAUDA, K.M., CLIFT, S., MARSHALL, F.F., MULLIGAN, R.C., and PARDOLL, D.M. (1993). High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res. 53, 2221-2226.
39. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of NKSF, a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
40. MANETTI, R., PARRONDI, P., GIUDIZI, M.G., PICCINI, M.P., MAGGI, E., TRINCHIERI, G., and ROMAGNANI, S. (1993), NKSF/IL12 induces T helper I specific immune responses and inhibits the development of IL4 producing Th cells. J. Exp. Med. 177, 1199-1204.
41. MATTNER, F., FISCHER, S., GUCKES, S., JIN, S., KAULEN, H., SCHMITT, E., RUDE, E., and GERMANN, T. (1993). The IL-12 subunit p40 specifically inhibits effects of the IL-12 heterodimer. Eur. J. Immunol. 23, 2202-2208.
42. MEHROTIA, P.T., WU, D., CRIM, J.A., MOSTOWSKI, H.S., and SIEGEL, J.P. (1993). Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J. Immunol. 151, 2444-2452.
43. MORGAN, R.A., COUTURE, L., ELROY-STEIN, O., RAGHEB, J., MOSS, B., and ANDERSON, W.F. (1992). Retroviral vectors containing putative internal ribosome entry sites: Development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res. 20, 1293-1299.
44. NAKAYAMA, D.K., GELLER, D.A., LOWENSTEIN, C.J., DAVIES, P., PITT, B.R., SIMMONS, R.L., and BILLIAR, T.R. (1992). Cytokines and lipopolysaccharides induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am. J. Respir. Cell Mol. Biol. 7, 471-476.
45. NASTALA, C.L., EDINGTON, H.D., STORKUS, W.J., and LOTZE, M.T. (1993). Recombinant murine IL-12 mediates regression of both subcutaneous and metastatic murine tumors. Surg. Forum 44,518-521.
46. NASTALA, C.L., EDINGTON, H., STORKUS, W., McKINNEY, T.G., BRUNDA, M., GATELY, M.K., WOLF, S.F., SCHREIBER, R., and LOTZE, M.T. (1994). Recombinant IL12 administration induces tumor regression in association with IFN7. J. Immunol. 153, 1697-1706.
47. NAUME, B., GATELY, M.K., and ESPEVIK, T. (1992). A comparative study of IL-12, IL-2 and IL-7 induced effects on immunomag-netically purified CD56-” NK cells. J. Immunol. 148, 2429.
48. NISHIHARA, K., MIYATAKE, S., SAKATA, T., YAMASHITA, J., KIKUSHI, H., KAWADE, Y., ZU, Y., NAMBA, Y., HA-NAOKA, M., and WATANABE, Y. (1988). Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lympho-cytes by retroviral expression of mouse 7-interferon complementary cDNA. Cancer Res. 48, 4730-4735.
49. NUSSLER, A.K., DI SILVIO, M., BILLIAR, T.R., HOFFMAN, R.A., GELLER, D.A., SELBY, R., MADARIAGA, J., and SIMMONS, R.L. (1992). Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176, 261-264.
50. PEAR, W.S., NOLAN, G.P., SCOTT, M.L., and BALTIMORE, D. (1993). Production of high titer helper-free retroviruses by transient transfection. Proc. Natl. Acad, Sci. USA 90, 8392-8396.
51. PORGADOR, A., TZEHOVAL, E., KATZ, A., VADAI, E., REVEL, M., FELDMAN, M., and EISENBACK, L. (1992). IL-6 gene transfection into Lewis lung carcinoma tumor cells supresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res. 52, 3679-3686.
52. PORGADOR, A., BANNERJI, R., WATANABE, Y., FELDMAN, H., GILBOA, E., and EISENBACH, L. (1993). Antimetastatic vaccination of tumor bearing mice with two types of IFN7 gene inserted tumor cells. J. Immunol. 150, 1458-1470.
53. SCHOENHAUT, D.S., CHUA, A.O., WOLITZKY, A.G., PHYLLIS, M., QUINN, P.M., DWYER, C., McCOMAS, W., FAMIL-LETTI, P., GATELY, M.K., and GUBLER, U. (1992). Cloning and expression of murine IL-12. J. Immunol. 148, 3433-3440.
54. STERN, A.S., PODLASKI, F.J., HULMES, J.D., PAN, Y.C.E., QUINN, P.M., and GATELY, M.K. (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87, 6808.
55. TAHARA, H., MUELLER, G.M., RICORDI, C., ROBBINS, P.D., and LOTZE, M.T. (1992). Islet cell transplantation facilitated by gene transfer. Transpl. Proc. 24, 2975-2976.
56. TAHARA, H., ZEH III, H.J., STORKUS, W.J., PAPPO, I., WATKINS, S., GUBLER, U., WOLF, S., ROBBINS, P.D., and LOTZE, M.T. (1994). Fibroblasts genetically engineered to secrete IL-12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54, 1-9.
57. TAHARA, H., ZITVOGEL, L., STORKUS, W.J., ZEH III, H.J., McKINNEY, T.G., SCHREIBER, R.D., GUBLER, U., GATELY, M.K., ROBBINS, P.D., and LOTZE, M.T. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. (Submitted for publication).
58. TEPPER, R.I., PATTENGALE, P.K., and LEDER, P. (1989). Murine IL-4 displays potent antitumor activity in vivo. Cell 57, 503-512.
59. TEPPER, R.I., and MULE, J.J. (1994). Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther. 5, 153-164.
60. TOWNSEND, S.E., and ALLISON, J.P. (1993). Tumor rejection after direct costimulation of CDS-I- T cells by B7 transfected melanoma cells. Science 259, 368-370.
61. WATANABE, Y., KURIBAYASHI, K., MIYATAKE, S., NISHIHARA, K., NAKAYAMA, E., TANIYAMA, T., and SAKOTA, T. (1989). Exogenous expression of mouse IFN7 cNA in mouse neuroblastoma Cl300 cells results in reduced tumorigenicity by augmented antitumor immunity. Proc. Natl. Acad. Sci. USA 86, 9456-9460.
62. WOLF, S.F., TEMPLE, P.A., KOBAYASHI, M., TRINCHIERI, G., and PERUSSIA, B. (1991). Cloning of cDNA for NKSF, a heterodimeric cytokine with multiple biologic effects on T and NK cells. J. Immunol. 146, 3074-3081.
63. ZEH III, H.J., HURD, S., STORKUS, W.J., and LOTZE, M.T. IL-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer. J. Immunother. 14, 155-161.